EGMSILVAPHL
SILVAPHL Corporate Disclosure — 16 November 2025
Announcement summary
- What happened
- SILVAPHL published a corporate disclosure on 16 November 2025. Read the full announcement for details.
- Company
- Silva Pharmaceuticals Limited
- Announcement published
Original announcement
The Board of Directors of the company has taken the following decisions, which are subject to the approval by the Shareholders at the upcoming EGM and BSEC. 1) Change of Company name and Amend the AoA; 2) Post-Facto Approval of Project Revisions; and 3) Revised Proposal for utilization of IPO Proceeds. (cont.)
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
কোম্পানির পরিচালনা পর্ষদ নিম্নলিখিত সিদ্ধান্তগুলি নিয়েছে, যা আসন্ন EGM এবং BSEC-তে শেয়ারহোল্ডারদের অনুমোদন সাপেক্ষে। ১) কোম্পানির নাম পরিবর্তন এবং AoA সংশোধন; ২) প্রকল্প সংশোধনের কার্যকর-পরবর্তী অনুমোদন; এবং ৩) IPO অর্থ ব্যবহারের জন্য সংশোধিত প্রস্তাব। (চলবে)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 69194a9cd64a2828d8c26a89
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SILVAPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.